Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 12.677% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. CCCn1c(C(C)NC(=O)c2ccccc2)n[nH]c1=S
b. Cc1cc(C)c(C(=O)C(C)OC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1C
Answer: a. CCCn1c(C(C)NC(=O)c2ccccc2)n[nH]c1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(C(C)NC(=O)c2ccccc2)n[nH]c1=S
CCCn1c(C(C)NC(=O)c2ccccc2)n[nH]c1=S
N-[1-(4-propyl-5-sulfanylidene-1H-1,2,4-triazol-3-yl)ethyl]benzamide